Option Care Health (OPCH) Cost of Revenue (2009 - 2026)

Option Care Health (OPCH) has 18 years of Cost of Revenue data on file, last reported at $1.2 billion in Q2 2026.

• Quarterly Cost of Revenue rose 2.45% year-over-year to $1.2 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $4.6 billion (up 6.76% YoY) and the FY2025 annual result came in at $4.6 billion, up 14.46% from the prior year.
• Cost of Revenue improved to $1.2 billion in Q2 2026, from $1.1 billion in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $1.2 billion in Q4 2025 to a low of $714.8 million in Q1 2022.
• A 5-year average of $956.1 million and a median of $942.7 million in 2024 frame the typical range for Cost of Revenue.
• Annual changes were most pronounced in 2024 — Cost of Revenue gained 22.89% — and 2026, when it gained 1.75%.
• Tracing OPCH's Cost of Revenue over 5 years: stood at $796.1 million in 2022, then climbed by 10.19% to $877.3 million in 2023, then grew by 22.89% to $1.1 billion in 2024, then gained by 9.69% to $1.2 billion in 2025, then decreased by 0.63% to $1.2 billion in 2026.
• The last three Cost of Revenue figures came in at $1.2 billion (Q2 2026), $1.1 billion (Q1 2026), and $1.2 billion (Q4 2025), per Business Quant data.